Goldline Pharmaceutical IPO Review & Recommendations

• Source: All the financial information for listed industry peers mentioned above is on a consolidated basis sourced fromthe Annual Reports of the peer company or their financial results uploaded on the NSE and BSE website for the yearended March 31, 2025

Notes:

• P/E Ratio has been computed based on the closing market price of equity shares on the NSE for Mono Pharmacare Limited and BSE for Chandra Bhagat Pharma Limited on April 29, 2026 divided by the Diluted EPS of March 31, 2025. RoNW is computed as net profit after tax divided by the closing net worth. Net worth has been computed as sum of share capital and reserves and surplus.
• NAV is computed as the closing net worth divided by the weighted average number of equity shares.